CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more
CeriBell, Inc (CBLL) - Total Liabilities
Latest total liabilities as of December 2025: $40.47 Million USD
Based on the latest financial reports, CeriBell, Inc (CBLL) has total liabilities worth $40.47 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CeriBell, Inc - Total Liabilities Trend (2022–2025)
This chart illustrates how CeriBell, Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CeriBell, Inc Competitors by Total Liabilities
The table below lists competitors of CeriBell, Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Georgia Capital PLC
PINK:GRGCF
|
USA | $3.84 Million |
|
Fulgent Sun International Holding Co Ltd
TW:9802
|
Taiwan | NT$7.57 Billion |
|
Chongqing Lummy Pharmaceutical
SHE:300006
|
China | CN¥910.32 Million |
|
Shanghai Kelai Mechatronics
SHG:603960
|
China | CN¥123.23 Million |
|
Karnov Group AB
ST:KAR
|
Sweden | Skr4.14 Billion |
|
Zhejiang Meili High Technology Co Ltd
SHE:300611
|
China | CN¥1.09 Billion |
|
Meridianlink Inc
NYSE:MLNK
|
USA | $544.29 Million |
|
BeiJing Certificate Authority Co Ltd
SHE:300579
|
China | CN¥600.99 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down CeriBell, Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CeriBell, Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CeriBell, Inc (2022–2025)
The table below shows the annual total liabilities of CeriBell, Inc from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $40.47 Million | +18.16% |
| 2024-12-31 | $34.25 Million | -79.99% |
| 2023-12-31 | $171.17 Million | -0.97% |
| 2022-12-31 | $172.86 Million | -- |